Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

INCB13739

Inquiry
Cat. No.: OB0425LY-176
Synonyms: 869974-19-6; INCB-13739; N-Methyl-5-[4-[1-[(1R)-3-oxospiro[2-benzofuran-1,3'-pyrrolidine]-1'-carbonyl]cyclopropyl]phenyl]pyridine-2-carboxamide; 2-Pyridinecarboxamide, N-methyl-5-(4-(1-(((1R)-3-oxospiro(isobenzofuran-1(3H),3'-pyrrolidin)-1'-yl)carbonyl)cyclopropyl)phenyl)-
Size: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg; 500 mg
CAS No.: 869974-19-6
Compound CID: 66662059
INCB13739

Specification

Description: INCB13739 is a selective and tissue-specific11β-HSD1 inhibitor.
Formula Weight: 467.52
Applications: INCB13739 can be used in type 2 diabetes mellitus (T2DM) and anti-obesity studies.
Storage: Storage at -20°C.
Formula: C28H25N3O4
Appearance: Solid
Purity: 99.79%, determined by LC-MS.
Solubility: DMSO
Pathway: Immunology/Inflammation; Vitamin D related/Nuclear receptor; Metabolic enzyme/Protease
Identity: Confirmed by NMR and LC-MS.
Target: Glucocorticoid receptor; Mineralocorticoid receptor; 11β-HSD

Library Information

Solubility: DMSO
Inquiry

Copyright © Protheragen. All rights reserves.